Melior Discovery

Melior Discovery, Inc., of Exton, PA, is a pioneer of high-throughput in vivo pharmacology applied to drug discovery and development. The company has developed a unique technology platform, theraTRACE®, that is used by pharmaceutical partners for drug profiling and repositioning generally, and the identification of new therapeutic indications specifically. The Company also leverages these core competences to provide high quality, cost effective in vivo pharmacology services including a broad suite of specialized disease models representing the following therapeutic areas:

• Obesity
• Psychotherapeutic
• Sleep/Wake
• Inflammation/Immunology
• Gastrointestinal
• Urogenital
• Diabetes
• Pain
• Neurodegeneration
• Cardiovascular
• Dermatology
• Allergy/Respiratory

Melior’s rodent PK models, range from a rapid PK screening service to multi-group custom PK study designs that are integral to the interpretation of drug properties and the ability to relate these to optimum dosing paradigms. Melior uses state-of-the-art high-throughput LC/MS/MS equipment in their bioanalytical lab to offer the most sensitive bioanalytical method possible.

www.meliordiscovery.com